Contract Administrator Nights
Pubblicato il 09-10-2026 - Biotecnologie - Farmacia - Chimica in Italia
As Clinical Trial Administrator, you will keep clinical trials in Italy moving with accuracy and pace. Based in Rome, you will support the local study team from start-up to close-out – managing trial documentation, tracking progress, coordinating vendors and making sure investigator sites' payments are on time. Your work keeps trials compliant and inspection-ready, so new treatments can progress towards the people living with serious chronic diseases who need them. What you'll bring
You pay close attention to detail, stay organised under pressure and like finding a practical way forward when issues come up. To succeed in this role, you will bring:
A Master's degree in Life Sciences (preferably Biotechnology, Pharmacy, Chemistry, Biology or CTF)
A solid understanding of clinical trial phases, regulatory guidelines, Good Clinical Practice (GCP) and ethical considerations.
Hands-on experience using Clinical Trial Management Systems (CTMS) and other digital tools to manage study documentation and track activities.
The ability to manage multiple tasks,
timelines and stakeholders and to keep milestones on track.
Strong written and verbal communication skills, and the ability to build good working relationships with internal and external stakeholders.
Analytical and problem-solving skills to resolve study-related issues and suggest practical improvements.
Integrity, sound judgement and a strong eye for detail.
Openness to new digital tools and ways of working, and the flexibility to adapt in a fast-paced, changing trial environment.
Useful, but not essential:
Experience in the pharmaceutical industry or a Clinical Research Organisation (CRO).
Certification or formal training in Clinical Research and Good Clinical Practice (GCP).
What you'll do
You will provide administrative and operational support across every phase of the trials run by the local study team – preparation, execution and close-out – making sure each study runs in line with regulatory requirements and the st